Target Price | $182.36 |
Price | $173.82 |
Potential | 4.91% |
Number of Estimates | 25 |
25 Analysts have issued a price target Procter & Gamble 2025 . The average Procter & Gamble target price is $182.36. This is 4.91% higher than the current stock price. The highest price target is $209.00 20.24% , the lowest is $163.00 6.22% . | |
A rating was issued by 31 analysts: 18 Analysts recommend Procter & Gamble to buy, 12 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Procter & Gamble stock has an average upside potential 2025 of 4.91% . Most analysts recommend the Procter & Gamble stock at Purchase. |
22 Analysts have issued a sales forecast Procter & Gamble 2025 . The average Procter & Gamble sales estimate is $85.6b . This is 2.06% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $86.5b 3.13% , the lowest is $84.8b 1.03% .
This results in the following potential growth metrics:
2024 | $84.0b | 2.48% |
---|---|---|
2025 | $85.6b | 1.90% |
2026 | $88.8b | 3.70% |
2027 | $92.2b | 3.86% |
2028 | $96.5b | 4.60% |
20 Analysts have issued an Procter & Gamble EBITDA forecast 2025. The average Procter & Gamble EBITDA estimate is $24.2b . This is 6.58% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $25.5b 12.09% , the lowest is $23.0b 1.40% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $23.1b | 9.60% |
---|---|---|
2025 | $24.2b | 4.79% |
2026 | $25.7b | 6.10% |
2027 | $27.3b | 6.43% |
2028 | $28.7b | 5.04% |
2024 | 27.48% | 6.95% |
---|---|---|
2025 | 28.26% | 2.84% |
2026 | 28.91% | 2.30% |
2027 | 29.63% | 2.49% |
2028 | 29.76% | 0.44% |
11 Procter & Gamble Analysts have issued a net profit forecast 2025. The average Procter & Gamble net profit estimate is $16.0b . This is 17.08% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $16.8b 22.93% , the lowest is $15.3b 12.07% .
This results in the following potential growth metrics and future Net Margins:
2024 | $14.2b | 2.03% |
---|---|---|
2025 | $16.0b | 12.80% |
2026 | $17.6b | 10.14% |
2027 | $18.9b | 7.37% |
2028 | $19.9b | 5.33% |
2024 | 16.87% | 0.43% |
---|---|---|
2025 | 18.67% | 10.67% |
2026 | 19.83% | 6.21% |
2027 | 20.50% | 3.38% |
2028 | 20.65% | 0.73% |
11 Analysts have issued a Procter & Gamble forecast for earnings per share. The average Procter & Gamble <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $6.79 . This is 17.07% higher than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $7.13 22.93% , the lowest is $6.50 12.07% .
This results in the following potential growth metrics and future valuations:
2024 | $6.02 | 2.03% |
---|---|---|
2025 | $6.79 | 12.79% |
2026 | $7.48 | 10.16% |
2027 | $8.03 | 7.35% |
2028 | $8.46 | 5.35% |
Current | 29.98 | 20.79% |
---|---|---|
2025 | 25.60 | 14.61% |
2026 | 23.24 | 9.22% |
2027 | 21.64 | 6.88% |
2028 | 20.55 | 5.04% |
Based on analysts' sales estimates for 2025, the Procter & Gamble stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 5.07 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 4.78 .
This results in the following potential growth metrics and future valuations:
Current | 5.18 | 11.40% |
---|---|---|
2025 | 5.07 | 2.06% |
2026 | 4.89 | 3.57% |
2027 | 4.71 | 3.72% |
2028 | 4.50 | 4.40% |
Current | 4.88 | 12.90% |
---|---|---|
2025 | 4.78 | 2.02% |
2026 | 4.61 | 3.57% |
2027 | 4.44 | 3.72% |
2028 | 4.24 | 4.40% |
Procter & Gamble...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.